Kura Oncology (KURA) Return on Capital Employed [ROCE] (2024 - 2026)
Kura Oncology (KURA) recorded Return on Capital Employed [ROCE] of -60.98% in Q2 2026, down 26.63 percentage points from -34.35% a year earlier and down 9.50 percentage points from the prior quarter.
Powered by 
Analysis
Kura Oncology (KURA) Return on Capital Employed [ROCE] (2024 - 2026) Analysis & Trends
For FY2025, Kura Oncology reported Return on Capital Employed [ROCE] of -48.02%, down 11.28 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] has a three-year change of -18.33 percentage points (FY2022 to FY2025).
- Across earlier years, Return on Capital Employed [ROCE] came in at -36.74% in FY2024 (+2.99 pp), -39.73% in FY2023 (-10.04 pp) and -29.69% in FY2022.
- The Q2 2026 figure is the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q1 2024.
- On a year-over-year basis, Return on Capital Employed [ROCE] has declined for six consecutive quarters, with an average year-over-year change of -18.23 percentage points over the last six quarters.
- Per Business Quant, the preceding three quarters came in at -51.48% (Q1 2026), -50.56% (Q4 2025) and -41.84% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Kura Oncology | 947.36 Mn | 947.36 Mn | 20.63 Mn | -60.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -60.98% |
| Mar 31, 2026 | -51.48% |
| Dec 31, 2025 | -50.56% |
| Sep 30, 2025 | -41.84% |
| Jun 30, 2025 | -34.35% |
| Mar 31, 2025 | -28.08% |
| Dec 31, 2024 | -31.50% |
| Sep 30, 2024 | -33.63% |
| Jun 30, 2024 | -19.87% |
| Mar 31, 2024 | -10.48% |
API Access
Kura Oncology Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=KURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "KURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=KURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();